Shilpa Medicare inks pact with United Nations-backed Medicines Patent Pool

26 Jun 2013 Evaluate

Shilpa Medicare and Gilead Sciences have inked pact with United Nations-backed Medicines Patent Pool by entering into agreement to increase the access to medicines for HIV/AIDS treatment. With this initiative, the company will be able to produce five key HIV medicines for sale in over 100 countries depending on the medicine.

As per the agreement, the Karnataka-based firm can produce tenofovir, emtricitabine, cobicistat, elvitegravir and a combination of the four known as -the Quad. For this it will pay 3-5% royalty to the patent-holder Gilead, depending on the medicine.

Shilpa Medicare Share Price

326.30 2.50 (0.77%)
16-Dec-2025 14:06 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1787.00
Dr. Reddys Lab 1280.95
Cipla 1501.65
Zydus Lifesciences 919.00
Lupin 2091.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×